BIONET Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 226.79 million compared to TWD 210.28 million a year ago. Net income was TWD 5.38 million compared to TWD 1.57 million a year ago. Basic earnings per share from continuing operations was TWD 0.11 compared to TWD 0.03 a year ago. Diluted earnings per share from continuing operations was TWD 0.11 compared to TWD 0.03 a year ago. Basic earnings per share was TWD 0.11 compared to TWD 0.03 a year ago. Diluted earnings per share was TWD 0.11 compared to TWD 0.03 a year ago. For the nine months, sales was TWD 702.27 million compared to TWD 588.23 million a year ago. Net income was TWD 29.03 million compared to TWD 6.63 million a year ago. Basic earnings per share from continuing operations was TWD 0.61 compared to TWD 0.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.61 compared to TWD 0.14 a year ago. Basic earnings per share was TWD 0.61 compared to TWD 0.14 a year ago. Diluted earnings per share was TWD 0.61 compared to TWD 0.14 a year ago.